(Press-News.org) (CHICAGO) – An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery.
"This breakthrough technology could save the lives of thousands of patients with heart valve disease who have no other therapeutic options," says Dr. Ziyad Hijazi, director of the Rush Center for Congenital and Structural Heart Disease and interventional cardiologist of the Rush Valve Clinic.
The treatment is offered through a multi-center, phase IIB cohort study called the PARTNER II (Placement of AoRTic traNscathetER valves) trial.
Aortic valve stenosis (AS) is a type of valvular heart disease characterized by an abnormal narrowing of the aortic valve opening. It is a condition that affects nearly 1.5 million Americans. It causes hardening or thickening of the aortic valve leaflets, which limits leaflet motion and obstructs oxygen-rich blood flow from the heart to the rest of the body. Patients with severe AS may have symptoms of chest pain, fatigue, shortness of breath, lightheadedness or fainting. Although AS typically progresses slowly without symptoms, once symptoms occur, treatment is required. Fifty percent of patients may not survive beyond one to three years.
Traditionally, patients with symptomatic AS undergo aortic valve replacement during an open-heart surgery to alleviate symptoms, improve survival and improve quality of life. However, many patients who are at very high risk for surgery, such as elderly, frail individuals with multiple health concerns, are considered inoperable.
The PARTNER II trial will compare a pioneering technology called the Edwards SAPIEN XT valve, which is made of bovine pericardial tissue leaflets hand-sewn onto a metal frame, and a new catheter delivery system called the Edwards NovaFlex delivery system, which navigates the heart from a small incision to the femoral artery in a patient's leg or through a small incision between the ribs and snaked up into the left ventricle. The Edwards NovaFlex delivery system positions the catheter inside the patient's original, collapsed valve, using a balloon to deploy the frame, which holds the artificial valve in place in order to restore normal blood flow. Both procedures are performed on a beating heart, without the need for open, cardiopulmonary bypass and its associated risks.
Annually, some 200,000 people in the U.S. need a new heart valve, but nearly half of them do not receive a new valve for a variety of reasons.
"Past study results show conclusively that transcatheter valve replacement is a safe and effective alternative to open surgery, which remains the 'gold standard' for most patients," says Hijazi.
Results from the first phase of the PARTNER trial showed that the rate of death from any cause at one year was 50.7 percent in the patients who received standard therapy, as compared to 30.7 percent of patients treated with transcatheter aortic valve replacement (TAVR).
The transcatheter valve procedures take about 90 minutes, compared with four to six hours for open-heart surgery. In open-heart surgery, the surgeon cuts through the breastbone, stops the heart, removes the valve and replaces it. Open-heart surgery can require a two- to three-month recovery period, compared to only a few days for the transcatheter approach.
The next generation Edwards SAPIEN XT valve in The PARTNER II trial was engineered to provide a better valve patterned after surgical heart valves and potentially decrease treatment complications.
The PARTNER trial is the world's first randomized, controlled trial of a transcatheter aortic heart valve. In this clinical phase IIB cohort, patients are randomized to receive either the new Edwards Sapien XT valve using the NovaFlex delivery system or the Edwards SAPIEN Transcatheter Heart Valve.
"The primary objective of the trial is to reduce death, major stroke and repeat hospitalization in these patients," says Hijazi. "Additionally, we hope to improve quality-of-life indicators."
The PARTNER II trial is one of the three latest, nationwide clinical trials for minimally invasive heart valve replacement being offered through the Rush Valve Clinic, where a team of cardiac surgical and interventional experts address diseases of the aortic, mitral and pulmonary valves.
The three clinical trials include:
PARTNER II trial for patients with aortic stenosis
COMPASSION trial for patients with a dysfunctional conduit – A phase II clinical trial using the SAPIEN Transcatheter Heart Valve in patients who have a dysfunctional conduit between the right ventricle and the pulmonary artery
EVEREST II trial for patients with mitral regurgitation – A continued access trial using the eValve MitraClip to treat a mitral valve leak.
###
For more information about the PARTNER trial or any of the other clinical trials at the Rush Valve Clinic, call 312-942-6800.
About the Rush Valve Clinic
To provide the best and most advanced care available for patients with valve disease, a diverse team of cardiac specialists at Rush University Medical Center opened the Rush Valve Clinic. The new clinic draws on the team's wide breadth of experience in surgical and interventional approaches to addressing diseases of the aortic, mitral and pulmonary valves.
At the Rush Valve Clinic, each patient meets with a team of specialists — including an interventional cardiologist, a cardiac surgeon and an echocardiographer — at the same time. These specialists then pool their expertise to present the patient with an individualized treatment plan on the same day. They offer a wide range of treatments — from open surgery to balloon valvuloplasty to innovative percutaneous valve repair and replacement procedures — for the full spectrum of valve conditions.
For patients who qualify, treatment plans may include participation in clinical trials of the latest minimally invasive procedures to treat valve disease. Such procedures, which can shorten recovery time and minimize the risks associated with open surgery, may offer life-saving options to patients who otherwise have none.
The Rush Valve Clinic team includes the following clinicians:
Rami Doukky, MD, cardiac imaging specialist
Mary Heitschmidt, RN, APN, CCRN, research coordinator
Ziyad M. Hijazi, MD, MPH, interventional cardiologist
Clifford Kavinsky, MD, PhD, interventional cardiologist
Robert J. March, MD, cardiac surgeon
Anthony Perez-Tamayo, MD, cardiac surgeon
Tiana Riley, MSN, RN, ACNP-BC, research coordinator
Jeffrey S. Soble, MD, cardiac imaging specialist
Heart valve replacement without opening the chest gives new option for non-operable patients
2011-06-25
ELSE PRESS RELEASES FROM THIS DATE:
200,000 patients treated for cardiac arrest annually in US hospitals, Penn study shows
2011-06-25
(PHILADELPHIA) -- More than 200,000 people are treated for cardiac arrest in United States hospitals each year, a rate that may be on the rise. The findings are reported online this week in Critical Care Medicine in a University of Pennsylvania Perelman School of Medicine-led study.
Though cardiac arrest is known to be a chief contributor to in-hospital deaths, no uniform reporting requirements exist across the nation, leaving experts previously unable to calculate its true incidence and study trends in cardiac arrest mortality and best practices in resuscitation care. ...
Invest in children's health, urges former US Surgeon General
2011-06-25
New Rochelle, NY, June 24, 2011—David Satcher, MD, PhD, former U.S. Surgeon General, describes childhood obesity as "one of the greatest threats to child and adult health that we are facing today," calling for an intensive effort to promote child health, in an editorial in the June issue of Childhood Obesity, a peer-reviewed journal published by Mary Ann Liebert, Inc. The editorial is available online.
A long-time advocate in the fight against obesity, Dr. Satcher released the first Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity during ...
Does Public Reporting of Medical Errors Increase Patient Safety or Lawsuits?
2011-06-25
KCRG TV reported that Iowa hospitals do not have to publically report medical errors. The question is how this influences patient safety in Iowa.
The hospitals claim that merely requiring reporting of medical errors to the state does not ensure that the errors will be corrected.
Scott McIntyre, spokesman for the Iowa Hospital Association, said to KCRG TV that, "Government regulation does not create that kind of buy-in or progress," and that "it can stifle innovation as providers focus on meeting the mandate and little more."
Minnesota's Experience
In ...
Ancient species of mayfly had short, tragic life
2011-06-25
CORVALLIS, Ore. – About 100 million years ago, a tiny mayfly had a problem.
Like most adult mayflies, she only had that one day to live anyway, so there was no time to waste. She took her mating flight, got fertilized, and was about to lay her eggs when something went horribly wrong. She got stuck in some oozing tree sap and died, preserved for all time in the magic of amber. There would be ho hatchlings.
It was a pretty rude ending to what was already going to be a short adulthood. But her personal tragedy proved fortunate for scientists. The tiny specimen – just described ...
Deep history of coconuts decoded
2011-06-25
The coconut (the fruit of the palm Cocos nucifera) is the Swiss Army knife of the plant kingdom; in one neat package it provides a high-calorie food, potable water, fiber that can be spun into rope, and a hard shell that can be turned into charcoal. What's more, until it is needed for some other purpose it serves as a handy flotation device.
No wonder people from ancient Austronesians to Captain Bligh pitched a few coconuts aboard before setting sail. (The mutiny of the Bounty is supposed to have been triggered by Bligh's harsh punishment of the theft of coconuts from ...
Apologies and Lawsuits: If the Defendant Is Sorry, Should You Care?
2011-06-25
Much has been written in recent years about the positive impact apologies may have in civil litigation, from personal injury cases like car accidents to medical malpractice. One of the foremost advocates of this idea, Professor Jennifer Robbennold of the University of Illinois College of Law, has published the results of a variety of empirical studies showing that apologies effectively encourage settlement of civil disputes.
But practical barriers to getting defense counsel to encourage clients to apologize exist. The biggest issue is the fact that such hearsay can be ...
Northern Eurasian snowpack could be a predictor of winter weather in US, team from UGA reports
2011-06-25
Every winter, weather forecasters talk about the snow cover in the northern U.S. and into Canada as a factor in how deep the deep-freeze will be in the states. A new study by researchers at the University of Georgia indicates they may be looking, at least partially, in the wrong place.
It turns out that snow piling up over a band of frozen tundra from Siberia to far-northern Europe may have as much effect on the climate of the U.S. as the much-better-known El Niño and La Niña.
The new work, just published in the International Journal of Climatology, reports that to ...
What Colorado Parents Should Know About the Family Car Doctrine
2011-06-25
When automobile accidents occur, drivers or their insurance companies, or both, are typically liable for any injury or property damage. However, when minor drivers are involved in car accidents, who is responsible for the resulting costs?
In some states, like Colorado, the liability may fall on the parents, who may or may not have heard about a law known as the family car doctrine. Parents should know this law's main points and how to financially protect themselves if their children are involved in automobile accidents while driving.
Family Car Doctrine
About 20 ...
Safer and more effective diabetes control with basal insulin analogs
2011-06-25
New Rochelle, NY, June 24, 2011—Basal insulin analogs have revolutionized diabetes care, and especially the treatment of type 2 diabetes, enabling patients to achieve better control of blood glucose levels while reducing hypoglycemic episodes. These revolutionary, long-acting basal insulin analogs, intended to replace the natural insulin missing in diabetes, and infusion pumps that provide subcutaneous, continuous delivery of insulin to mimic the function of a normal pancreas, are described in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal ...
Pruhealth Becomes Nectar's Exclusive Healthcare Partner
2011-06-25
PruHealth customers can now collect up to 200 Nectar points and 10 Vitality points each week when buying GBP20 worth of healthy foods* during the weekly shop at Sainsbury's, under PruHealth's new and exclusive partnership with Nectar, the largest loyalty programme in the UK.
Enhancing PruHealth's existing partnership with Sainsbury's**, the innovative insurer that rewards healthy behaviour has become Nectar's exclusive healthcare partner within the programme.
Policyholders with Nectar membership can now receive 10 Nectar points per GBP1 spent in Sainsbury's on over ...